FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer Diagnoses Still Lagging; Cancer and Family Health; New Type of Lung Cancer

2.

Glioblastoma cells can 'unstick' from their neighbors to become more deadly

3.

Getting More Done With Less Blood.

4.

Patients with resected head and neck cancers may benefit clinically from an investigational personalized vaccine.

5.

Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot